Clinical Studies
The Eye Institute of Utah specializes in comprehensive Pharmaceutical and Medical Device clinical trials. We are also actively involved in global research and development of diagnostic equipment, alongside investigator-initiated studies. Our clinical studies focus on assessing the safety and effectiveness of new devices, medications, and procedures for treating various ocular conditions.
How Do Clinical Trials Benefit Our Patients?
As a participant, you will have access to state-of-the-art technologies and treatments before they are commercially available, allowing you to experience these innovative advancements firsthand. Our site has been a pioneer in introducing various treatments that are now widely adopted within the ophthalmology community. Our state-of-the-art clinic and surgical facilities are fully equipped to provide services such as laser vision correction, retina-vitreous care, glaucoma treatment, and cataract surgery, all under one roof.
Our Clinical Research Team
Our team includes three principal investigators and three sub-investigators on-site, with research experience spanning 5 to over 40 years. These investigators are highly skilled, well-trained in Good Clinical Practices (GCP), and knowledgeable about the FDA Code of Regulations. Established in 1980 as the first and largest office-based eye surgical center in Utah, The Eye Institute of Utah draws the majority of its study patients from our own patient population.
Our study department is supported by a dedicated team of full-time Clinical Research Coordinators and Research Technicians. Our mission is to deliver exceptional support to our community, sponsors, and patients, prioritizing patient safety and confidentiality. We are committed to excellence in clinical research, ensuring the highest quality work with integrity and efficiency. By investing in clinical research, we strive to enhance the quality of eye care for generations to come.
Current Clinical Studies
Cataract Surgery
NCT04553523: Hydrus® Microstent Study
The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will undergo uncomplicated cataract surgery with placement of a monofocal intraocular lens (IOL), followed by implantation of the Hydrus Microstent.
- Sponsor: Alcon Research
- Principal Investigator: Kristin O. Bretz, MD
- Clinicaltrials.gov
- Status: Open to enrollment
NCT07218783: Bimatoprost Implant System and SpyGlass IOL Study
Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution (Tigris) – This trial is a randomized study to evaluate and compare the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
- Sponsor: SpyGlass Pharma, Inc.
- Principal Investigator: Zachary J. Zavodni, MD
- Clinicaltrials.gov
- Status: Open to enrollment
Glaucoma Studies
NCT04949802: Glaucoma Surgery Using the ViaLase Laser System
The purpose of study is to obtain initial evidence of safety of femtosecond laser glaucoma surgery using the ViaLase Laser for the treatment of open angle glaucoma. The ViaLase Laser System is intended to create apertures through the trabecular meshwork to reduce intraocular pressure in patients with open angle glaucoma.
- Sponsor: ViaLase, Inc.
- Principal Investigator: Kristin O. Bretz, MD
- Clinicaltrials.gov
- Status: Enrollment now CLOSED
Dry Eye Disease
Please check back for future dry eye disease clinical trials.
Refractive Surgery (LASIK/PRK/ICL)
NCT07412496: A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy.
This is a multicenter, double-masked study to evaluate the use of Topical Ocular BL1332 for the management of post-operative pain after Photorefractive Keratectomy (PRK) surgery.
- Sponsor: Bausch & Lomb Inc.
- Principal Investigator: Zachary J. Zavodni, MD
- Clinicaltrials.gov
- Status: Open to enrollment
Presbyopia
Please check back for future presbyopia clinical trials.
Corneal Disease (Keratoconus, Fuch’s Dystrophy, NK)
Please check back for future corneal disease clinical trials.
To learn more about it and find out if you are a candidate, please fill out the form below or contact our Study Department at (801) 263-5735.
Page Updated:
The Eye Institute of Utah Doctors have either authored or reviewed and approved this content.